Tag: drug

Posted on

Teva finds positive results in advanced trials for asthma drug – Yahoo News


Globes

Teva finds positive results in advanced trials for asthma drug
Yahoo News
TEL AVIV (Reuters) – Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an …
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 5 news articles »

View full post on asthma – Google News

Posted on

Teva finds positive results in advanced trials for asthma drug – Reuters


Globes

Teva finds positive results in advanced trials for asthma drug
Reuters
Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients …
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 4 news articles »

View full post on asthma – Google News

Posted on

India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will …
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

Posted on

India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will …
Cipla launches Serroflo in Germany and Sweden with affordable high quality …pharmabiz.com

all 6 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca starts Phase III program for asthma drug tralokinumab – Pharmaceutical Business Review

AstraZeneca starts Phase III program for asthma drug tralokinumab
Pharmaceutical Business Review
AstraZeneca has started the Phase III program for an investigational human monoclonal antibody tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by the company's global biologics research and …

View full post on asthma – Google News

Posted on

AstraZeneca starts final-stage tests on severe asthma drug – Reuters


Reuters UK

AstraZeneca starts final-stage tests on severe asthma drug
Reuters
Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year. (Reporting by Ben Hirschler, Editing …
AstraZeneca Starts Phase III Trial For Asthma Drug TralokinumabLondon South East
AstraZeneca Starts Late-stage Study Of Tralokinumab – Quick FactsRTT News

all 4 news articles »

View full post on asthma – Google News

Posted on

Malaria Drug, Artesunate, Brings Asthma Sufferers Breathing Relief With Fewer … – Medical Daily


Medical Daily

Malaria Drug, Artesunate, Brings Asthma Sufferers Breathing Relief With Fewer …
Medical Daily
Allergic asthma is one of the most common asthmas, affecting over 50 percent of the 20 million Americans who suffer from asthma, according to the Asthma and Allergy Foundation of America. It's triggered by typical allergens like dust, pollen, pet …

View full post on asthma – Google News